Biomarkers in Triple-Negative Breast Cancer: State-of-the-Art and Future Perspectives

Triple-negative breast cancer (TNBC) is a heterogeneous group of tumors characterized by aggressive behavior, high risk of distant recurrence, and poor survival. Chemotherapy is still the main therapeutic approach for this subgroup of patients, therefore, progress in the treatment of TNBC remains an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cocco, Stefania, Piezzo, Michela, Calabrese, Alessandra, Cianniello, Daniela, Caputo, Roberta, Di Lauro, Vincenzo, Fusco, Giuseppina, di Gioia, Germira, Licenziato, Marina, de Laurentiis, Michelino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369987/
https://www.ncbi.nlm.nih.gov/pubmed/32605126
http://dx.doi.org/10.3390/ijms21134579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369987/
https://www.ncbi.nlm.nih.gov/pubmed/32605126
http://dx.doi.org/10.3390/ijms21134579

Ejemplares similares